Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Decision

Decision

Prioritisation programme

Prioritisation programme

Showing 1 to 10 of 389

TitlePrioritisation programmeDecisionDecision date
Fenfluramine for treating seizures associated with Dravet syndrome in people under 2 yearsMedicines evaluationNot selected
Secukinumab for treating moderate to severe hidradenitis suppurativa in people 12 to 17 yearsMedicines evaluationNot selected
Mirikizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 yearsMedicines evaluationNot selected
Bee venom immunotherapy for generalised or systemic IgE-mediated allergic reactions to bee venomMedicines evaluationNot selected
Wasp venom immunotherapy for treating wasp venom allergyMedicines evaluationNot selected
Tirzepatide for treating type 2 diabetes in people 10 to 17 years [ID6539]Medicines evaluationNot selected
Siponimod for treating multiple sclerosis in people 10 to 17 years [TSID12317]Medicines evaluationNot selected
Pegunigalsidase alfa every 4 weeks for treating Fabry disease [TSID12346]Medicines evaluationNot selected
Ruxolitinib for treating acute graft-versus-host disease after allogeneic stem cell transplant in people 28 days to 17 years [ID6410]Medicines evaluationNot selected
Peginterferon alfa-2a for treating polycythaemia vera or essential thrombocythaemia [TSID12325]Medicines evaluationNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All